Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 446 of 6351
-
New injection after liver ablation aims to stop colorectal cancer in its tracks
Disease control Not yet recruitingThe goal of this clinical trial is to learn if a new injectable drug (IP-001), administered after standard liver tumor ablation, can help prevent cancer from returning in people (males/females, ≥18 years old) with colorectal cancer that has spread only to the liver. The study wil…
Phase 2/3 • Sponsor: Immunophotonics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New pill plus immunotherapy targets Hard-to-Treat cancers
Disease control Not yet recruitingThis is a single-arm, open-label, multicenter, Phase Ib/II clinical trial of CVL237 tablets in combination with serplulimab injection for the treatment of advanced solid tumors with PTEN loss or low expression
Phase 2 • Sponsor: Convalife (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New surgical trick could save diabetic feet from amputation
Disease control Not yet recruitingThe purpose of this study is to evaluate the safety and clinical performance of transverse tibial bone transport in patients with chronic ischemic and diabetic lower extremity ulcers. This study will assess wound healing outcomes and limb preservation in a population with limited…
Sponsor: Biodynamik, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a simple drug prevent dangerous bleeding in C-Sections?
Prevention Not yet recruitingInvestigating the efficacy of tranexamic acid (TXA) as a prophylactic agent in reducing postpartum haemorrhage (PPH) among patients undergoing cesarean section (CS) in SQUH: a prospective randomized controlled trial.
Phase 3 • Sponsor: Sultan Qaboos University • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
Shorter radiation with Real-Time adjustments could reduce side effects
Disease control Not yet recruitingThis phase II, registry-based cohort-multiple randomized controlled trial (cmRCT) evaluates whether daily online adaptive radiotherapy (ART) enables the safe delivery of hypofractionated, iso-biologically equivalent (EQD2) external beam radiotherapy compared with standard-of-care…
Phase 2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Triple-Drug cocktail takes aim at rare, aggressive cancers
Disease control Not yet recruitingTo explore the Objective Response Rate (ORR) of Benmelstobart combined with Anlotinib and chemotherapy as first-line treatment for large-cell neuroendocrine carcinoma of the lung (LCNEC) and extrapulmonary neuroendocrine carcinoma (EP-NEC)
Phase 2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New combo therapy aims to boost depression treatment success
Symptom relief Recruiting nowRepetitive Transcranial Magnetic stimulation (rTMS) is an FDA-approved therapy for treatment resistant depression (TRD) that involves brief magnetic stimulation pulses on the dorsolateral prefrontal cortex (DLPFC) brain region. But studies of rTMS alone show remission rates of \~…
Phase 2 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New hope for tough breast cancers: smart switch to targeted drug combo
Disease control Not yet recruitingThis is a multicenter, two-arm, exploratory clinical study designed to evaluate the efficacy and safety of a response-guided neoadjuvant treatment strategy in patients with HER2-positive early or locally advanced breast cancer. Breast cancer is the most common malignancy in wome…
Phase 2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for hard-to-treat head and neck cancer: drug combo enters phase 2 trial
Disease control Not yet recruitingThis is a multicenter study comprising two phases: a run-in phase, including only patients receiving ficerafusp alfa and nivolumab, and a randomized phase, which corresponds to a randomized, open-label, phase II comparative study. The primary objective is to compare the objectiv…
Phase 2 • Sponsor: Groupe Oncologie Radiotherapie Tete et Cou • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Bone-Stretching trick may help heal diabetic foot wounds
Disease control Not yet recruitingThis study is a single-center, prospective, randomized controlled trial aimed at evaluating whether periosteal distraction combined with autologous split-thickness skin grafting can significantly improve graft survival rate at postoperative day 14 compared with skin grafting alon…
Sponsor: Hu Zhicheng • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for tough depression: ALTO-207 trial launches
Symptom relief Recruiting nowThe purpose of this trial is to measure depressive symptoms following treatment with ALTO-207 compared with placebo in participants with TRD.
Phase 2 • Sponsor: Alto Neuroscience • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Pocket-Sized defibrillators for volunteers could revolutionize cardiac arrest response
Disease control Not yet recruitingThe goal of this clinical trial is to learn the feasibility of equipping the volunteer community responders (VCR) with the mobile external automated defibrillators (mAEDs) for the management of adults experiencing out-of-hospital cardiac arrest (OHCA) patients. It will also provi…
Sponsor: Singapore General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New immune cell therapy takes on tough pancreatic cancer
Disease control Not yet recruitingChemotherapy is the first-line treatment for advanced-stage pancreatic cancer patients. However, drug resistance always occurs within 6 months. For these patients, no effective treatment is available. Chimeric antigen receptor macrophage targeting C-MET( CAR-M-C-MET) is a novel c…
Phase 1 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Brain cell injection offers new hope for advanced Parkinson's patients
Disease control Not yet recruitingThis clinical trial is designed to evaluate the safety, tolerability and preliminary efficacy of a single injection of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in patients with Parkinson's Disease who have previously undergone deep brain stimulation or deep brai…
Phase 1 • Sponsor: iRegene Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Engineered immune cells take aim at Hard-to-Treat myeloma
Disease control Recruiting nowThe study proposed here intends to evaluate the safety and efficacy of escalating doses of autologous PMCC-COE-KMA CAR T-cells administered to patients with relapsed/refractory multiple myeloma that expresses the KMA. The PMCC-COE-KMA CAR T-cells will be produced using LV and adm…
Phase 1 • Sponsor: Peter MacCallum Cancer Centre, Australia • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Can a heart drug shield kidneys during bypass surgery?
Prevention Not yet recruitingCardiac surgery-associated acute kidney injury (CSA-AKI) is a common and serious perioperative complication, independently associated with prolonged hospitalization, increased mortality, and progression to chronic kidney disease. Despite advances in surgical techniques and postop…
Phase 4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Gene test could tailor chemo for tough pancreatic cancers
Knowledge-focused Not yet recruitingPancreatic cancer exhibits significant heterogeneity, which poses a major challenge in selecting the best treatment for patients from the very beginning of care. Modern oncology recognizes the use of companion biomarkers to guide targeted therapy or immune checkpoint inhibitors. …
Sponsor: Institut Paoli-Calmettes • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
A traditional mexican technique, with a Partner's help, may transform the birth experience
Symptom relief Recruiting nowThe main objective of this study is to examine the effect of the rebozo technique, applied with partner support, on labor pain and birth satisfaction in primiparous pregnant women. This research is planned as a randomized controlled experimental study. A total of 64 pregnant wome…
Sponsor: Istanbul Saglik Bilimleri University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Can diabetes drugs tame joint inflammation in psoriatic arthritis?
Disease control Recruiting nowPsoriatic arthritis (PsA) is a chronic inflammatory condition that affects the joints but can also have an effect on multiple parts of the body. This study will assess if the effectiveness of Glucagon-like peptide-1 (GLP-1) medications used to treat type 2-diabetes and weight man…
Phase 4 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Can a cell injection calm the gut after a stem cell transplant?
Disease control By invitation onlyThis study focuses on patients with gastrointestinal-dominant acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation. AmiMetosai Injection combined with corticosteroids is administered as first-line treatment. The objective is to evaluate…
Early phase 1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC